{"id":7908,"date":"2025-11-10T10:22:27","date_gmt":"2025-11-10T02:22:27","guid":{"rendered":"https:\/\/wccbiomedical.com\/?p=7908"},"modified":"2025-11-13T16:00:03","modified_gmt":"2025-11-13T08:00:03","slug":"major-breakthrough-to-the-pain-relief-market-by-wcc-biomedical","status":"publish","type":"post","link":"https:\/\/wccbiomedical.com\/en\/news\/major-breakthrough-to-the-pain-relief-market-by-wcc-biomedical\/","title":{"rendered":"WCC Biomedical Sets New Benchmark in Microarray Technology, Targets US$10B Global Pain-Relief Market"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

WCC Biomedical\u00a0<\/strong>announced an remarkable achievement as its next-generation pain-relief product WCC-301<\/b> successfully completed the US FDA Pre-IND meeting<\/b> and has now entered GLP toxicology studies, marking a major step toward Phase I\/IIa clinical trials next year. Meeting US FDA\u2019s large-scale batch manufacturing requirements demonstrates that WCC\u2019s microarray platform has reached a level of high uniformity, reproducibility, and true mass-production capability\u2014a standard many global competitors have not been able to achieve.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Powered by the proprietary WINMAP\u2122 microarray platform, WCC-301 delivers pain relief within 5\u201315 minutes, <\/b>significantly faster than conventional patches that require 4\u20136 hours. With zero gastrointestinal side effects, the product aims to redefine pain-management standards <\/b>and tap into the US$10B global pain-relief market,<\/b> with licensing discussions ongoing with several major pharmaceutical companies\u2014including a leading Japanese transdermal drug maker. The Asia-Pacific licensing opportunity is estimated to exceed US$300M.<\/b><\/p>\n

In addition, WCC Biomedical became the only Taiwanese microarray company invited by BARDA to the Vaccine Innovation Forum,<\/b> showcasing its mRNA microarray vaccine delivery technology recognized for improving stability, reducing cold-chain needs, and enabling self-administration. This international recognition further validates WCC\u2019s precision microarray engineering and scalable manufacturing excellence.<\/b><\/p>\n

With clinical development progressing and strong commercial interest, WCC is preparing to enter the capital market next year via an emerging-stock listing and public offering, <\/b>aiming to accelerate global commercialization and strengthen Taiwan\u2019s position in microarray innovation.<\/p>

\u201cFrom Taiwan to the world \u2014 redefining drug delivery through precision microarray technology,\u201d\nsaid Dr. Liu Dajiao, Chairman of WCC Biomedical.<\/h3>\n

\n<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

For further reading: Taiwan’s Economic Daily (\u7d93\u6fdf\u65e5\u5831) – A Historic Leap for Taiwan Biotech \u2014 WCC Biomedical Reaches FDA-Grade Manufacturing with Its Microarray Platform, Positioning Its Fast-Acting Pain-Relief Therapy for the NT$300 Billion Market (article in Chinese)<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

WCC Biomedical\u00a0announced an remarkable achievement as its next-generation pain-relief product WCC-301 successfully completed the US FDA Pre-IND meeting and has now entered GLP toxicology studies, marking a major step toward Phase I\/IIa clinical trials next year. Meeting US FDA\u2019s large-scale batch manufacturing requirements demonstrates that WCC\u2019s microarray platform has reached a level of high uniformity, […]<\/p>\n","protected":false},"author":1,"featured_media":3844,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"ocean_post_layout":"","ocean_both_sidebars_style":"","ocean_both_sidebars_content_width":0,"ocean_both_sidebars_sidebars_width":0,"ocean_sidebar":"0","ocean_second_sidebar":"0","ocean_disable_margins":"enable","ocean_add_body_class":"","ocean_shortcode_before_top_bar":"","ocean_shortcode_after_top_bar":"","ocean_shortcode_before_header":"","ocean_shortcode_after_header":"","ocean_has_shortcode":"","ocean_shortcode_after_title":"","ocean_shortcode_before_footer_widgets":"","ocean_shortcode_after_footer_widgets":"","ocean_shortcode_before_footer_bottom":"","ocean_shortcode_after_footer_bottom":"","ocean_display_top_bar":"default","ocean_display_header":"default","ocean_header_style":"","ocean_center_header_left_menu":"0","ocean_custom_header_template":"0","ocean_custom_logo":0,"ocean_custom_retina_logo":0,"ocean_custom_logo_max_width":0,"ocean_custom_logo_tablet_max_width":0,"ocean_custom_logo_mobile_max_width":0,"ocean_custom_logo_max_height":0,"ocean_custom_logo_tablet_max_height":0,"ocean_custom_logo_mobile_max_height":0,"ocean_header_custom_menu":"0","ocean_menu_typo_font_family":"0","ocean_menu_typo_font_subset":"","ocean_menu_typo_font_size":0,"ocean_menu_typo_font_size_tablet":0,"ocean_menu_typo_font_size_mobile":0,"ocean_menu_typo_font_size_unit":"px","ocean_menu_typo_font_weight":"","ocean_menu_typo_font_weight_tablet":"","ocean_menu_typo_font_weight_mobile":"","ocean_menu_typo_transform":"","ocean_menu_typo_transform_tablet":"","ocean_menu_typo_transform_mobile":"","ocean_menu_typo_line_height":0,"ocean_menu_typo_line_height_tablet":0,"ocean_menu_typo_line_height_mobile":0,"ocean_menu_typo_line_height_unit":"","ocean_menu_typo_spacing":0,"ocean_menu_typo_spacing_tablet":0,"ocean_menu_typo_spacing_mobile":0,"ocean_menu_typo_spacing_unit":"","ocean_menu_link_color":"","ocean_menu_link_color_hover":"","ocean_menu_link_color_active":"","ocean_menu_link_background":"","ocean_menu_link_hover_background":"","ocean_menu_link_active_background":"","ocean_menu_social_links_bg":"","ocean_menu_social_hover_links_bg":"","ocean_menu_social_links_color":"","ocean_menu_social_hover_links_color":"","ocean_disable_title":"default","ocean_disable_heading":"default","ocean_post_title":"","ocean_post_subheading":"","ocean_post_title_style":"","ocean_post_title_background_color":"#0a0a0a","ocean_post_title_background":0,"ocean_post_title_bg_image_position":"","ocean_post_title_bg_image_attachment":"","ocean_post_title_bg_image_repeat":"","ocean_post_title_bg_image_size":"","ocean_post_title_height":0,"ocean_post_title_bg_overlay":0.5,"ocean_post_title_bg_overlay_color":"","ocean_disable_breadcrumbs":"default","ocean_breadcrumbs_color":"","ocean_breadcrumbs_separator_color":"","ocean_breadcrumbs_links_color":"","ocean_breadcrumbs_links_hover_color":"","ocean_display_footer_widgets":"default","ocean_display_footer_bottom":"default","ocean_custom_footer_template":"0","ocean_post_oembed":"","ocean_post_self_hosted_media":"","ocean_post_video_embed":"","ocean_link_format":"","ocean_link_format_target":"self","ocean_quote_format":"","ocean_quote_format_link":"post","ocean_gallery_link_images":"off","ocean_gallery_id":[],"footnotes":""},"categories":[67],"tags":[],"class_list":["post-7908","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","entry","has-media"],"acf":[],"categories_names":["News"],"post_class":[["post-7908","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","entry","has-media"]],"author_avatar":[""],"featured_video":null,"_links":{"self":[{"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/posts\/7908","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/comments?post=7908"}],"version-history":[{"count":32,"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/posts\/7908\/revisions"}],"predecessor-version":[{"id":8048,"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/posts\/7908\/revisions\/8048"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/media\/3844"}],"wp:attachment":[{"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/media?parent=7908"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/categories?post=7908"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wccbiomedical.com\/en\/wp-json\/wp\/v2\/tags?post=7908"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}